Troriluzole Individual Patient IND Expanded Access Program

Inclusion Criteria: Patient has confirmed diagnosis of spinocerebellar ataxia (SCA) In the opinion and clinical judgement of the Physician, potential benefit outweighs potential risk of receiving an investigational therapy, based on the individual patient's medical history and program eligibility criteria and judged by the treating physician to be medically suitable for treatment with troriluzole. Adequate hepatic function Exclusion Criteria: Patient is known to have acute or chronic liver disease that is clinically significant in the Physician's judgment Patient has a history of a clinically significant medical condition that would interfere with the patient's ability to comply with the expanded access treatment instructions or would place the patient at increased risk